United States · Bill · HR
H.R. 4106 (118th)
Test Strip Access Act of 2023
Introduced
14 June 2023
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
27 May 2025
Summary
Test Strip Access Act of 2023 This bill specifically allows state and tribal opioid response grants, which are administered by the Substance Abuse and Mental Health Services Administration, to be used for fentanyl or xylazine test strips.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 14 June 2023
Introduced in House (PDF)
Introduced in House · EN · 14 June 2023
Introduced in House
summary · EN · 14 June 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/4106
- Open data entity: https://api.congress.gov/v3/bill/118/hr/4106